People

Anatol Kreitzer

MapLight Therapeutics chief discovery officer, developing neural-circuit discovery methods. Previously a UCSF physiology and neurology professor researching basal ganglia function, Parkinson’s disease and dyskinesia. Studied at Berkeley and Harvard and trained at Stanford.